Sparta Science Raises $16M Series B Round to Define the Movement Vital Sign and Reimagine Musculoskeletal Diagnostic Health Processes

By Sparta Science

March 6, 2020

GSR Ventures U.S. led the round, joined by Arsenal Growth and existing investors

March 6, 2020

MENLO PARK, Calif.--(BUSINESS WIRE)--Sparta Science, the Silicon Valley company that applies data and technology in pursuit of human resilience, today announced a $16 million Series B funding round led by GSR Ventures U.S., a private investment firm primarily focused on early-stage companies in the United States developing AI-enabled healthcare technology, enterprise software, and consumer platforms. Arsenal Growth, the only firm to have managed investment funds for the United States Army and for the United States Treasury Department, also joined the round alongside existing investors, bringing the total capital raised to date to approximately $26 million.

“We’re thankful to our new partners at GSR Ventures U.S. and Arsenal Growth who also believe that a validated, deep awareness of musculoskeletal health is crucial to overall health assessments. Our two-million-plus Sparta Scans provide a foundation for a better understanding of the human body, its resilience and true potential.”

To Read the Full Article Click Here

Wake Forest Men’s Basketball Extends Contract with Sparta

Partnership Puts Rockies at Forefront of Training Science

How the Seattle Mariners Involve their Players in the Ongoing Development of their High Performance Model